Identification of pro-interleukin 16 as a novel target of MAP kinases in activated T lymphocytes

European Journal of Immunology

Volumn 34, Issue 2, 2004, Pages 587-597

  Laurence, Arian ^a   Astoul, Emmanuelle ^b   Hanrahan, Sarah ^c   Totty, Nick ^a   Cantrell, Doreen ^c  

^a THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^b BABRAHAM INSTITUTE   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

IL 16; IL 2; SDF1 ; Serine kinases; T cell receptor

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 16; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN ANTIBODY; PROTEIN SERINE KINASE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; INTERLEUKIN 16 PRECURSOR; MORPHOLINE DERIVATIVE; ORGANIC COMPOUND; PD 98058; PROTEIN PRECURSOR; SERINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE IDENTIFICATION; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; T LYMPHOCYTE; CHEMISTRY; ENZYMOLOGY; GEL CHROMATOGRAPHY; IMMUNOLOGY; MASS SPECTROMETRY; METABOLISM; PHOSPHORYLATION; SERODIAGNOSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CHROMATOGRAPHY, AGAROSE; CHROMONES; ENZYME INHIBITORS; HUMANS; INTERLEUKIN-16; LYMPHOCYTE ACTIVATION; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; ORGANIC CHEMICALS; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN PRECURSORS; SERINE; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; T-LYMPHOCYTES;

EID: 1642373183     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324598     Document Type: Article

References (39)

1. Rincon, M., MAP-kinase signaling pathways in T cells. Curr. Opin. Immunol. 2001. 13: 339-345.
2. Cantrell, D., Protein kinase B (Akt) regulation and function in T lymphocytes. Semin. Immunol. 2002. 14: 19-26.
3. Cantrell, D., Regulation and function of serine kinase networks in lymphocytes. Curr. Opin. Immunol. 2003. 3: 294-298.
4. + T cells. Immunol. Rev. 2003. 192: 131-142.
5. Cantrell, D. A., Transgenic analysis of thymocyte signal transduction. Nat. Rev. Immunol. 2002. 2: 20-27.
6. Lafont, V., Astoul, E., Laurence, A., Liautard, J. and Cantrell, D., The T cell antigen receptor activates phosphatidylinositol 3-kinase-regulated serine kinases protein kinase B and ribosomal S6 kinase 1. FEBS Lett. 2000. 486: 38-42.
7. Matthews, S. A., Rozengurt, E. and Cantrell, D., Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/Protein kinase Cmu. J. Biol. Chem. 1999. 274: 26543-26549.
8. Kane, S., Sano, H., Liu, S. C., Asara, J. M., Lane, W. S., Garner, C. C. and Lienhard, G. E., A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J. Biol. Chem. 2002. 277: 22115-22118.
9. Manning, B. D. and Cantley, L. C., Hitting the target: emerging technologies in the search for kinase substrates. Sci. STKE 2002. 162: PE49.
10. Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J. and Cantley, L. C., Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell 2002. 10: 151-162.
11. Zhang, H., Zha, X., Tan, Y., Hornbeck, P. V., Mastrangelo, A. J., Alessi, D. R., Polakiewicz, R. D. and Comb, M. J., Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. J. Biol. Chem. 2002. 277: 39379-39387.
12. Astoul, E., Laurence, A. D., Totty, N., Beer, S., Alexander, D. R. and Cantrell, D. A., Approaches to define antigen receptor-induced serine kinase signal transduction pathways. J. Biol. Chem. 2003. 278: 9267-9275.
13. Beer, S., Simins, A. B., Schuster, A. and Holzmann, B., Molecular cloning and characterization of a novel SH3 protein (SLY) preferentially expressed in lymphoid cells. Biochim. Biophys. Acta 2001. 1520: 89-93.
14. Reif, K., Burgering, B. M. and Cantrell, D. A., Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J. Biol. Chem. 1997. 272: 14426-14433.
15. Davies, S. P., Reddy, H., Caivano, M. and Cohen, P., Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 2000. 351: 95-105.
16. Cruikshank, W. W., Kornfeld, H. and Center, D. M., Interleukin16. J. Leukoc. Biol. 2000. 67: 757-766.
17. Center, D. M., Kornfeld, H., Ryan, T. C. and W.W., C., Interleukin 16: implications for CD4 functions and HIV-1 progression. Immunol. Today 2000. 21: 273-280.
18. Chupp, G. L., Wright, E. A., Wu, D., Vallen-Mashikian, M., Cruikshank, W. W., Center, D. M., Kornfeld, H. and Berman, J. S., Tissue and T cell distribution of precursor and mature IL-16. J. Immunol. 1998. 161: 3114-3119.
19. Baier, M., Bannert, N., Werner, A., Lang, K. and Kurth, R., Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc. Natl. Acad. Sci. USA 1997. 94: 5273-5277.
20. Reif, K., Nobes, C. D., Thomas, G., Hall, A. and Cantrell, D. A., Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways. Curr. Biol. 1996. 6: 1445-1455.
21. Izquierdo, M., Leevers, S. J., Marshall, C. J. and Cantrell, D., p21ras couples the T cell antigen receptor to extracellular signal-regulated kinase 2 in T lymphocytes. J. Exp. Med. 1993. 178: 1199-1208.
22. Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D. and Downward, J., Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994. 370: 527-532.
23. Dalby, K. N., Morrice, N., Caudwell, F. B., Avruch, J. and Cohen, P., Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J. Biol. Chem. 1998. 273: 1496-1505.
24. Center, D. M. and Cruikshank, W., Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J. Immunol. 1982. 128: 2563-2568.
25. Cruikshank, W. and Center, D. M., Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF). J. Immunol. 1982. 128: 2569-2574.
26. + T cells in vitro. J. Immunol. 1996. 156: 310-315.
27. + T cells is independent of transcription and translation. Evidence for constitutive protein synthesis and storage. J. Immunol. 1995. 155: 2902-2910.
28. + T cells is activation dependent. J. Immunol. 1999. 162: 1287-1293.
29. Keane, J., Nicoll, J., Kim, S., Wu, D. M., Cruikshank, W. W., Brazer, W., Natke, B., Zhang, Y., Center, D. M. and Kornfeld, H., Conservation of structure and function between human and murine IL-16. J. Immunol. 1998. 160: 5945-5954.
30. Zhang, Y., Center, D. M., Wu, D. M., Cruikshank, W. W., Yuan, J., Andrews, D. W. and Kornfeld, H., Processing and activation of pro-interleukin-16 by caspase-3. J. Biol. Chem. 1998. 273: 1144-1149.
31. Zhang, Y., Kornfeld, H., Cruikshank, W. W., Kim, S., Reardon, C. C. and Center, D. M., Nuclear translocation of the N-terminal prodomain of interleukin-16. J. Biol. Chem. 2001. 276: 1299-1303.
32. Dumont, F. J., Staruch, M. J., Fischer, P., Dasilva, C. and Ramon, C., Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J. Immunol, 1998. 160: 2579-2589.
33. Egerton, M., Fitzpatrick, D. R., Catling, A. D. and Kelso, A., Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway. Eur. J. Immunol. 1996. 26: 2279-2285.
34. Jorritsma P, J., Brogdon J, L. and Brogdon K., B., Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells. J. Immunol. 2003. 170: 2427-2434.
35. Muhlhahn, P., Zweckstetter, M., Georgescu, J., Ciosto, C., Renner, C., Lanzendorfer, M., Lang, K., Ambrosius, D., Baier, M., Kurth, R. and Holak, T. A., Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site. Nat. Struct. Biol. 1998. 5: 682-686.
36. Wilson, K. C., Center, D. M., Cruikshank, W. W. and Zhang, Y., Binding of HTLV-1 tax oncoprotein to the precursor of interleukin-16, a T cell PDZ domain-containing protein. Virology 2003. 306: 60-67.
37. Hung, A. Y. and Sheng, M., PDZ domains: structural modules for protein complex assembly. J. Biol. Chem. 2002. 277: 5699-5702.
38. Bannert, N., Vollhardt, K., Asomuddinov, B., Haag, M., Konig, H., Norley, S. and R., K., PDZ domain-mediated interaction of interleukin-16 precursor proteins with myosin phosphatase targeting subunits. J. Biol. Chem 2003, in press.
39. Astoul, E., Watton, S. and Cantrell, D., The dynamics of protein kinase B regulation during B cell antigen receptor engagement. J. Cell Biol. 1999. 145: 1511-1520.